Your browser doesn't support javascript.
loading
Reduction in peanut reaction severity during oral challenge after 12 months of epicutaneous immunotherapy.
Bégin, Philippe; Bird, John Andrew; Spergel, Jonathan M; Campbell, Dianne E; Green, Todd D; Bee, Katharine J; Lambert, Romain; Sampson, Hugh A; Fleischer, David M.
Affiliation
  • Bégin P; CHU Sainte-Justine, Montreal, QC, Canada.
  • Bird JA; University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Spergel JM; Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Campbell DE; DBV Technologies, Montrouge, France.
  • Green TD; The Children's Hospital at Westmead, Sydney, NSW, Australia.
  • Bee KJ; DBV Technologies, Montrouge, France.
  • Lambert R; UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA, USA.
  • Sampson HA; DBV Technologies, Montrouge, France.
  • Fleischer DM; DBV Technologies, Montrouge, France.
Allergy ; 76(12): 3835-3838, 2021 12.
Article in En | MEDLINE | ID: mdl-34492123
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arachis / Peanut Hypersensitivity Limits: Humans Language: En Journal: Allergy Year: 2021 Document type: Article Affiliation country: Canada
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arachis / Peanut Hypersensitivity Limits: Humans Language: En Journal: Allergy Year: 2021 Document type: Article Affiliation country: Canada